9. CONFLICT OF INTEREST
All members of the EAU-ASCO Penile Cancer Guidelines working group have provided disclosure statements of all relationships that they have that might be perceived as a potential source of a conflict of interest. This information is provided below and is also publicly available on the EAU website: http://uroweb.org/guideline/penile-cancer/.
This Guidelines document was developed with the financial support of the European Association of Urology. No external sources of funding and support have been involved. The EAU is a nonprofit organisation, and funding is limited to administrative assistance and travel and meeting expenses. No honoraria or other reimbursements have been provided.
Disclosures: The EAU Guidelines Office certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g. employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received or pending) are the following: O. Brouwer reported trial participation for NKI AVL. S.T. Tagawa reported trial participation and receiving honoraria or consultant fees from Novartis. B.E. Ayres reported trial participation for MSD. M. Albersen reported trial participation for MSD and receiving grants and research support from Astellas Pharma. M.S. van der Heijden reported receiving honoraria or consultation fees from Bristol-Myers Squibb Company, Daiichi-Sankyo, Merck & Co., AstraZeneca, Seattle Genetics, and Astellas, and receiving grants or research support from Bristol-Myers Squibb Company, Roche, AstraZeneca, 4SC AG, Pfizer, Janssen – Oncology, and Merck Sharp & Dohme B.V. P. Spiess reported trial participation for International Penile Cancer Advanced Trial (US ECOG/NCI). D.F. Sánchez Martínez reported trial participation for Instituto de Patología e Investigación. L.C. Pagliaro reported receiving grants or research support from Astellas Pharma US. P. Oliveira, A. Parnham, C. Protzel, J.M. Crook, P.A.S. Johnstone, C.A. Pettaway, R.B. Rumble, J. Osborne, K. Manzie, J.D. Marcus, L. Barreto, H.A. Garcia-Perdomo, I. Greco and K. Patterson have nothing to declare.